HCA Healthcare, Inc. (HCA) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of HCA Healthcare, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
HCA
HCA Healthcare, Inc.
$402.59HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$762.63HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
Total return — HCA vs REGN
growth of $100 · dividends reinvested · last 15yHCA +1412.3%REGN +2024.4%REGN compounded faster
HCA REGN
HCA vs REGN: by the numbers
- •HCA is the larger company ($87.16B vs $78.57B market cap).
- •HCA trades at the lower trailing earnings multiple (13.61 vs 18.86 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (27.86% vs 8.89% net margin).
- •HCA grew revenue faster over the past five years (7.73% vs 4.64% CAGR).
- •HCA pays the higher dividend yield (0.76% vs 0.48%).
Metrics side by side
Valuation
| Metric | HCA | REGN |
|---|---|---|
| P/E ratio | 13.61 | 18.86 |
| Forward P/E | 13.38 | 14.62 |
| P/S ratio | 1.17 | 5.24 |
| P/B ratio | N/A | 2.10 |
| PEG ratio | 0.57 | 3.38 |
| EV / EBITDA | 8.90 | 19.81 |
| FCF yield | 8.83% | 4.62% |
Profitability
| Metric | HCA | REGN |
|---|---|---|
| Gross margin | 34.92% | 88.11% |
| Operating margin | 15.67% | 24.74% |
| Net margin | 8.89% | 27.86% |
| ROE | -112.56% | 11.15% |
| ROIC | 18.53% | 8.51% |
Dividends
| Metric | HCA | REGN |
|---|---|---|
| Dividend yield | 0.76% | 0.48% |
| Payout ratio | 10.48% | 8.45% |
Growth (annualized)
| Metric | HCA | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 7.73% | 4.64% |
| EPS CAGR (5Y) | 20.90% | 5.70% |
| FCF CAGR (5Y) | 1.92% | 17.30% |
| Total return CAGR (5Y) | 11.12% | 5.99% |
Frequently asked
- Which has the lower trailing P/E, HCA or REGN?
- HCA has the lower trailing P/E: HCA trades at 13.61 and REGN at 18.86. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, HCA or REGN?
- Over the past five years, HCA grew revenue faster — HCA at a 7.73% CAGR versus REGN at 4.64%.
- Does HCA or REGN pay a bigger dividend?
- HCA yields 0.76% and REGN yields 0.48% based on trailing dividends and the latest price.
- Is HCA or REGN more profitable?
- REGN runs the higher net margin — HCA at 8.89% versus REGN at 27.86%.
- How have HCA and REGN total returns compared?
- Over the past 10 years, HCA delivered 18.86% and REGN delivered 6.10% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HCA Healthcare P/E ratioRegeneron Pharmaceuticals P/E ratioHCA Healthcare dividend yieldRegeneron Pharmaceuticals dividend yieldHCA Healthcare ROERegeneron Pharmaceuticals ROEHCA Healthcare operating marginRegeneron Pharmaceuticals operating marginHCA Healthcare revenue growthRegeneron Pharmaceuticals revenue growthHCA Healthcare free cash flowRegeneron Pharmaceuticals free cash flow
HCA Healthcare & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.